Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Tacc3
REST API REST API
Rattus norvegicus
Tacc3 is differentially expressed in 53 experiments: 24 organism parts: frontal cortex, hippocampus, ... (22 more);, 5 disease states: normal, BDL 7 days, ... (3 more);, 6 cell types 23 compound treatments 2 biosource types and 15 other conditions.
Orthologs TACC3 (Gallus gallus)   TACC3 (Homo sapiens)   Tacc3 (Mus musculus)   tacc3 (Danio rerio)   ENSCING00000013819 (Ciona intestinalis)   tacc (Drosophila melanogaster)   tacc3 (Xenopus tropicalis)   (Compare orthologs)
Gene Ontology Term cytoplasm, cell proliferation, neurogenesis, response to stress, protein domain specific binding, cytoplasmic sequestering of transcription factor, hemopoiesis, centrosome, regulation of cell cycle, microtubule cytoskeleton organization, cerebral cortex development, regulation of microtubule-based process, interkinetic nuclear migration, astral microtubule organization
InterPro Term Tropomyosin, Orphan nuclear receptor, NOR1 type, Transforming acidic coiled-coil-containing
UniProt Accession D3Z962
Search EB-eye ENSRNOG00000017259
Show more properties
Experimental Factors
organism part

studied in E-GEOD-2880, E-GEOD-13793, E-GEOD-13319, E-GEOD-19830, E-GEOD-20388, ... (8 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

cell type

studied in E-GEOD-5940, E-GEOD-830, E-TABM-130

Factor Value U/D Experiments
spermatocyte
1
E-TABM-130
laminin binding germ cell
1
E-GEOD-830
oligodendrocyte progenitor cell
1
E-GEOD-5940
tubular somatic cell
1
E-GEOD-830
oligodendrocyte
1
E-GEOD-5940
Sertoli cell
1
1
E-TABM-130


disease state

studied in E-GEOD-1872, E-MTAB-104, E-MEXP-2583

Factor Value U/D Experiments
BDL 7 days
1
E-MEXP-2583
bladder carcinoma
1
E-MTAB-104
breast carcinoma
1
E-GEOD-1872
sham
1
E-MEXP-2583
normal
11
2
E-MTAB-104, E-GEOD-1872


Compound treatment

studied in E-GEOD-7002, E-GEOD-1872, E-GEOD-5509, E-MTAB-797, E-GEOD-6119, ... (8 experiments)

Factor Value U/D Experiments
bromoethylamine 20 micromolar
1
E-MTAB-797
monocrotaline 90 micromolar
1
E-MTAB-797
chlormadinone 8 micromolar
1
E-MTAB-797
terbinafine 0.6 micromolar
1
E-MTAB-797
tannic acid 0.4 micromolar
1
E-MTAB-797
tannic acid 2 micromolar
1
E-MTAB-797
17 more value(s).


biosource type

studied in E-MEXP-1069

Factor Value U/D Experiments
frozen_sample
1
E-MEXP-1069
fresh_sample
1
E-MEXP-1069


clinical treatment

studied in E-MEXP-976, E-MTAB-104

Factor Value U/D Experiments
spinal nerve transection
1
E-MEXP-976
implanted tumor
1
E-MTAB-104
sham surgery
1
1
E-MEXP-976
sham implantation
1
E-MTAB-104
no implantation
1
E-MTAB-104


developmental stage
studied in E-MEXP-570

genetic modification
studied in E-GEOD-6428

genotype
studied in E-MTAB-322, E-GEOD-20214

growth condition
studied in E-MEXP-2863, E-GEOD-20659, E-TABM-501

injury
studied in E-MEXP-1278

irradiate
studied in E-GEOD-6299

material type
studied in E-MEXP-2527

protocol
studied in E-GEOD-20895

protocol type
studied in E-MEXP-532, E-MEXP-1565

sampling time point
studied in E-MTAB-797

strain or line
studied in E-MTAB-322, E-TABM-457, E-AFMX-7, E-GEOD-4028, E-MTAB-323 ... (5 experiments)

temperature
studied in E-MEXP-1069

tissue region
studied in E-GEOD-21681

treatment
studied in E-GEOD-15184, E-GEOD-7002, E-GEOD-29110, E-GEOD-24672, E-GEOD-16981, ... (6 experiments)

Processing time: 1.596 secs.
 
Gene Expression Atlas 2.0.13- 4/23/12 11:55:46 AM